Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5BSI

Crystal structure of Y36A mutant of human macrophage migration inhibitory factor

5BSI の概要
エントリーDOI10.2210/pdb5bsi/pdb
関連するPDBエントリー5BS9 5BSC 5BSJ
分子名称Macrophage migration inhibitory factor, SULFATE ION, GLYCEROL, ... (4 entities in total)
機能のキーワードisomerase, surface, mutation
由来する生物種Homo sapiens (Human)
細胞内の位置Secreted: P14174
タンパク質・核酸の鎖数8
化学式量合計99424.74
構造登録者
Pantouris, G.,Lolis, E. (登録日: 2015-06-02, 公開日: 2015-09-30, 最終更新日: 2023-09-27)
主引用文献Pantouris, G.,Syed, M.A.,Fan, C.,Rajasekaran, D.,Cho, T.Y.,Rosenberg, E.M.,Bucala, R.,Bhandari, V.,Lolis, E.J.
An Analysis of MIF Structural Features that Control Functional Activation of CD74.
Chem.Biol., 22:1197-1205, 2015
Cited by
PubMed Abstract: For more than 15 years, the tautomerase active site of macrophage migration inhibitory factor (MIF) and its catalytic residue Pro1 have been being targeted for the development of therapeutics that block activation of its cell surface receptor, CD74. Neither the biological role of the MIF catalytic site nor the mechanistic details of CD74 activation are well understood. The inherently unstable structure of CD74 remains the biggest obstacle in structural studies with MIF for understanding the basis of CD74 activation. Using a novel approach, we elucidate the mechanistic details that control activation of CD74 by MIF surface residues and identify structural parameters of inhibitors that reduce CD74 biological activation. We also find that N-terminal mutants located deep in the catalytic site affect surface residues immediately outside the catalytic site, which are responsible for reduction of CD74 activation.
PubMed: 26364929
DOI: 10.1016/j.chembiol.2015.08.006
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 5bsi
検証レポート(詳細版)ダウンロードをダウンロード

227561

件を2024-11-20に公開中

PDB statisticsPDBj update infoContact PDBjnumon